2019 Nov 22 [cited 2021 Dec 1]
Fill Out Patient Forms 3
Additional reasons to seek medical advice: Symptoms suggesting pregnancy (nausea beyond typical tirzepatide side effects, breast tenderness, fatigue) Signs of infection (fever, unusual vaginal discharge, pelvic pain) Significant mood changes or depression related to menstrual irregularities Concerns about fertility or family planning while taking tirzepatide Proactive communication with your healthcare team ensures that menstrual changes are appropriately evaluated and managed, optimizing both the metabolic benefits of tirzepatide treatment and your overall reproductive health
HOWEVER, IN THE EVENT THAT CUSTOMER UTILIZES OR CAUSES OTHERS TO USE THESE PRODUCTS OUTSIDE OF THE ABOVE RESTRICTIONS, CUSTOMER IS ACCEPTING SUCH RISKS OF DOING SO ON ITSELF, ABSOLVING SELLER OF ANY RESPONSIBILITY FOR SUCH CUSTOMER ACTIONS, AND SPECIFICALLY AGREES TO INDEMNIFY AND HOLD SELLER HARMLESS FOR ANY CLAIMS MADE BY ANY THIRD PARTY BECAUSE OF SUCH CUSTOMER ACTION
Product Name: 5-Amino-1MQ Strength: 10mg Chemical Name: 5-Amino-1-methylquinolinium CAS Number: 685079-15-6 Molecular Formula: CHN Molecular Weight: 159.21 g/mol Appearance: YellowOrange Crystalline Solid Classification: Small-Molecule NNMT Inhibitor Purity: Verified by analytical testing prior to release Analytical Methods: HPLC, Mass Spectrometry (MS) Research areas commonly associated with this compound include: Metabolic & weight research Store lyophilized material refrigerated at 28C for routine storage
